Showing results (151-160 of 829) with videos related to
Sort By:
Pageof 83
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2006
Predictive value of a positive fecal occult blood test increases as the severity of CKD worsensEdmund J Bini, Aditi Kinkhabwala, David S GoldfarbThe Urologic Clinics of North America|November 27, 2012
Pharmacologic treatment of kidney stone diseaseBrian H Eisner, David S Goldfarb, Gyan PareekClinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Asymptomatic nephrolithiasis detected by ultrasoundAmar D Bansal, Jennifer Hui, David S GoldfarbClinical Practice and Cases in Emergency Medicine|August 26, 2021
A Report of Two Cases: Unlearning Lactic AcidosisSanjay Mohan, David S Goldfarb, Robert S HoffmanUrological Research|March 1, 2006
Chitosan does not reduce post-prandial urinary oxalate excretionJoshua Wolf, John R Asplin, David S GoldfarbNephron Extra|May 8, 2014
Symptomatic central venous stenosis in a hemodialysis patient leading to loss of arteriovenous access: a case report and literature reviewVasishta S Tatapudi, Noam Spinowitz, David S GoldfarbArchives of Internal Medicine|April 1, 1981
Recurrent thrombotic thrombocytopenic purpura after viral infection. Clinical and histologic simulation of chronic glomerulonephritisA Wasserstein, G Hill, S Goldfarb, et al.Cancer Research|December 1, 1978
Partial "feedback control" of beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity in primary hepatocellular carcinomasA D Mitchell, T D Pugh, S GoldfarbClinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluriaDavid S Goldfarb, Frank Modersitzki, John R AsplinJournal of the American Society of Nephrology : JASN|February 1, 1995
Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trialsT F Imperiale, S Goldfarb, J S BernsPageof 83